Carly Geier
Registered Nurse · Cape Coral, FLNPI 1922761774
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 557 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Among registered nurse clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 557 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$904
- Corium, LLC$756
- Teva Pharmaceuticals USA, Inc.$633
- Johnson & Johnson$619
- plus $4K from 18 others
What the payments were for
- Food & beverage$9,605100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $1,618 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 101 | $1,224 |
| Alkermes, Inc. | 47 | $904 |
| Corium, LLC | 37 | $756 |
| Teva Pharmaceuticals USA, Inc. | 35 | $633 |
| Johnson & Johnson | 31 | $619 |
| Otsuka America Pharmaceutical, Inc. | 29 | $524 |
| Axsome Therapeutics, Inc. | 29 | $462 |
| Supernus Pharmaceuticals, Inc. | 31 | $425 |
| Lundbeck LLC | 26 | $405 |
| Vanda Pharmaceuticals Inc. | 15 | $384 |
| Neurocrine Biosciences, Inc. | 12 | $316 |
| Ironshore Pharmaceuticals Inc. | 18 | $271 |
| Almatica Pharma LLC | 11 | $182 |
| Tempus AI, Inc | 9 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $163 |
| Noven Therapeutics, LLC | 8 | $143 |
| Collegium Pharmaceutical, Inc. | 7 | $128 |
| Tris Pharma Inc | 7 | $112 |
| E.r. Squibb & Sons, L.L.C. | 4 | $64 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| Indivior Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$104
How this compares
$9,619 in reported general payments places this provider in the 95th percentile of 185 registered nurse providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LybalviOlanzapine/Samidorphan Malate | 27 | $44,144 |
| VraylarCariprazine Hcl | 21 | $29,792 |
| CaplytaLumateperone Tosylate | 17 | $27,578 |
| RexultiBrexpiprazole | 11 | $22,055 |
| TrintellixVortioxetine Hydrobromide | 24 | $12,534 |
| BelsomraSuvorexant | 17 | $7,490 |
| Chlorpromazine Hcl | 24 | $3,712 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 21 | $3,033 |
| Clozapine | 29 | $1,877 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 24 | $1,384 |
| Quetiapine Fumarate | 73 | $1,360 |
| Trazodone Hcl | 63 | $1,254 |
| Aripiprazole | 38 | $1,080 |
| Eszopiclone | 13 | $1,020 |
| Bupropion XlBupropion Hcl | 64 | $896 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alkermes, Inc.Lybalvi | $904 | $44,14427 claims |
| AbbVieVraylar | $1,618 | $29,79221 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,224 | $27,57817 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $524 | $22,05511 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $163 | $12,53424 claims |
| Almatica Pharma LLCSertraline Hcl | $182 | $32980 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 185 registered nurse providers in Florida.
Other registered nurse in Cape Coral
- Dianne DavidDeland$10K
- Rachel SimsFort Myers$8K
- Shannon BagnellAtlantis$5K
- Marcia JohnsonMiami$4K
- Brigitte MartinezOdessa$3K
- Diana MaciasPort Charlotte$2K
- Alexandria HardyWeston$2K
- Pilar TatumPalm Harbor$2K
- Tran GallagherOrlando$2K
- Brett MastromatteoWest Palm Beach$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.